Aim and Scope: Journal of Basic and Clinical Pathophysiology is dedicated to the fast publication of original research papers related, in the broadest sense, to basic and clinical aspects of pathophysiology. Papers in all areas with an emphasis on molecular, cellular and particularly with a mechanistic attitude will be considered for publication.
Submission:Submission of a paper to Journal of Basic and Clinical Pathophysiology is understood to imply that it deals with original material not previously published, and that it is not being considered for publication elsewhere. Manuscripts submitted under multiple authors are reviewed on the assumption that all listed authors have agreed on the submission and that a copy of the final manuscript has been approved by all authors. Manuscripts are first reviewed by the editorial board to ensure their appropriateness relevant to the framework of the journal. The manuscript would be peer-reviewed by related specialists. If accepted, the article shall not be published elsewhere in the same form, without the consent of the Editor and Publisher. Manuscripts of length up to a maximum of 5000 words will be considered for publication. Articles should be written in English, should be complete in all respects, and double spaced with wide margins. The author must declare that all experiments on human subjects were conducted with the adequate understanding and written consent of the subjects. When experimental animals are used, the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Submission items include Cover Letter and copyright transfer agreement, Reviewer Suggestions (at least 3), Manuscript including Title Page, Abstract, Manuscript Text, References and Tables/Figure Legends), Tables and Figures. Text files (double-spaced) of the manuscript should be supplied in Microsoft Word format. Authors should send their submission electronically through our online submission system at: http://JBCP.shahed.ac.ir
Covering Letter and copyright transfer agreement: All submissions to the journal should be accompanied by a completed signed covered letter approved and signed by all authors of the manuscript in addition to copyright transfer agreement.
Journal of Basic and Clinical Pathophysiology follows COPE’s Guidelines for Journal Editors and is committed to ensuring ethics in publication and quality of articles. Therefore, compliance to ethical standards is expected for all involved parties including Authors, Editors, Reviewers, and the Publisher, as follows:
Authors should present an objective discussion of the significance of research work as well as sufficient detail and references to permit others to replicate the experiments. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. Review articles should also be objective, comprehensive, and accurate accounts of the state of the art. The authors should ensure that their work is entirely original works, and if the work and/or words of others have been used, this has been appropriately acknowledged. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. Authors should not submit articles describing essentially the same research to more than one journal. The corresponding author should ensure that there is a full consensus of all co-authors in approving the final version of the paper and its submission for publication.
Editors should evaluate manuscripts exclusively on the basis of their academic merit. An editor must not use unpublished information in the editor's own research without the express written consent of the author. Editors should take reasonable responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper.
Any manuscripts received for review must be treated as confidential documents. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviews should be conducted objectively, and observations should be formulated clearly with supporting arguments, so that authors can use them for improving the paper. Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
D) Ethical guidelines
Ethical considerations must be addressed according to the COPE policy.
E) Conflicts of interest
Authors must acknowledge and declare any sources of funding and potential conflicting interest, such as receiving funds or fees by, or holding stocks and shares in, an organization that may profit or lose through publication of your paper. Declaring a competing interest will not lead to automatic rejection of the paper, but we would like to be made aware of it.
This Journal Use the ICMJE Form for Disclosure of Potential Conflicts of Interest to generate a disclosure statement for your manuscript.
Peer Review System: Manuscripts submitted to the journal are first evaluated by members of the editorial board for their relevance and novelty and methodology of the research. Peer reviews are done anonymously. Comments of the reviewers are then sent to the corresponding author for modifications and the new version of the manuscript would again peer-reviewed for a second time by one of the previous reviewers.
Title Page: This page should contain the following items: (i) complete title (preferably no chemical formulas or arbitrary abbreviations); (ii) full names of all authors; (iii) complete affiliations of all authors; (iv) the number of text pages of the whole manuscript (including figures and tables) and the number of figures and tables; (v) the name and complete address of the corresponding author (as well as telephone number, facsimile number and E-mail address, and if available URL address) to whom correspondence and proofs should be sent; (vi) acknowledgements.
Running Title: A maximum of 40 characters with spaces should be provided.
Abstract: An Abstract of up to 250 words describing the purpose of the study, the methods, the results, and the conclusion should precede the main text.
Keywords: 3-6 keywords or phrases should be provided; preferably, these should be selected from the body of the text.
In general, the main text of the manuscript should be organized as follows:
Introduction, Materials and methods, Results, Discussion, Acknowledgements and References
References according to Vancouver style: The authors are responsible for the accuracy of the bibliographic information. References should be numbered in parentheses consecutively in order of citation in the text. All references cited in the text should be listed at the end of the manuscript on a separate page. All items in the list of references should be cited in the text and, conversely, all references cited in the text must be presented in the list. Personal communications and unpublished data including manuscripts submitted, but not yet accepted for publication should not be used as a reference, nonetheless, they may be placed in parentheses in the text. In the case of seven or more authors, the names of the first six authors followed by et al, should be listed. Listed below are sample references to a journal and a book respectively:
1. Gleckman R, Mory J. Diabetes-related foot infection. Contemporary Internal Medicine 1994; 6(2): 57-62.
2. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Ed., 1986, Academic Press, San Diego.
Clinical Trial Registration: This journalrequires that randomized controlled trials be registered according to policies accepted by International Committee of Medical Journal Editors and World Association of Medical Editors (WAME). In order to be considered for publication, trials that begin enrolment of patients after January 2008 must register in a public trials registry at or before the onset of enrolment, and trials that began patient enrolment on or before this date must register anytime before submission to the journal. The registration number of the trial and the name of the trial registry must be mentioned in title page. Acceptable trial registries are the following:http://rctregistry.tums.ac.irhttp://www.clinicaltrials.govhttp://www.anzctr.org.auhttp://isrctn.orghttp://www.irct.irhttp://www.umin.ac.jp/ctr
Illustrations: Illustrations will appear either across a single column (8 cm) or a whole page (15cm). The illustrations should be numbered in Arabic numerals according to the sequence of appearance in the text, where they are referred to as Fig. 1, Fig. 2, etc. Figure legends should be concise and clear and should not duplicate the body of the text. Each illustration must have a title and an explanatory legend. The title should be part of the legend and not be reproduced on the figure itself. The legends should be placed on a separate page at the end of the manuscript and begin with the number of the illustration they refer to. All symbols and abbreviations used in the figure must be explained.
Tables: Tables should be so constructed that they, together with their captions and legends, will be intelligible with minimal reference to the text. Tables of numerical data should each be typed (with double-spacing) on a separate page, numbered in sequence in Arabic numerals (Table 1, 2, etc.) and referred to in the text as Table 1, Table 2, etc. The title of the table should appear above it. A detailed description of its contents and footnotes should be given below the body of the table.
Proofs: Authors will receive proofs by email. Only printer's errors may be corrected; no change in, or additions to, the edited manuscript will be allowed at this stage. The corrected proofs must be returned within 72 hours after receipt by email. If the Publisher receives no reply, the assumption will be made that there are no errors to correct and the article will be published.
Reprints: A minimum of 1 reprint of each paper will be provided free of charge to the author(s).
Editorial Office: Neurophysiology Research Center, 3rd floor, Research Centers, No. 1471, North Kargar Ave., Tehran, Iran. P.O. Box: 14185/564
Tel: (+98 21) 66419568
Fax: (+98 21) 66468993